Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Metronidazole only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Metronidazole only product in vaginal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Bismuth biskalcitrate and metronidazole and tetracycline only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Metronidazole only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Diloxanide and metronidazole only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Metronidazole only product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Metronidazole only product in dental dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Metronidazole only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only metronidazole in rectal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely metronidazole 5 milligram/1 milliliter conventional release solution for infusion (clinical drug) |
Has basis of strength substance (attribute) |
True |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely metronidazole 5 milligram/1 milliliter conventional release solution for infusion (clinical drug) |
Has precise active ingredient |
True |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Metronidazole 10 mg/g cutaneous gel |
Has precise active ingredient |
True |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Metronidazole 10 mg/g cutaneous gel |
Has basis of strength substance (attribute) |
True |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Metronidazole 1 g rectal suppository |
Has basis of strength substance (attribute) |
True |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Metronidazole 1 g rectal suppository |
Has precise active ingredient |
True |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Metronidazole 7.5 mg/mL cutaneous lotion |
Has basis of strength substance (attribute) |
True |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Metronidazole 7.5 mg/mL cutaneous lotion |
Has precise active ingredient |
True |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely metronidazole 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has precise active ingredient |
True |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely metronidazole 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has basis of strength substance (attribute) |
True |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Metronidazole 5 mg/mL solution for injection |
Has basis of strength substance (attribute) |
True |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Metronidazole 5 mg/mL solution for injection |
Has precise active ingredient |
True |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely diloxanide 250 milligram and metronidazole 200 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely diloxanide 250 milligram and metronidazole 200 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule |
Has precise active ingredient |
False |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Furazolidone 6 mg/mL and metronidazole (as metronidazole benzoate) 20 mg/mL oral suspension |
Has basis of strength substance (attribute) |
True |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing furazolidone and metronidazole (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only furazolidone and metronidazole (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only furazolidone and metronidazole in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Furazolidone- and metronidazole-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Chlorhexidine gluconate 2.5 mg/g and metronidazole 10 mg/g dental gel |
Has precise active ingredient |
True |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Chlorhexidine gluconate 2.5 mg/g and metronidazole 10 mg/g dental gel |
Has basis of strength substance (attribute) |
True |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing chlorhexidine and metronidazole (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only chlorhexidine and metronidazole (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Chlorhexidine- and metronidazole-containing product in dental dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only chlorhexidine and metronidazole in dental dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing lidocaine and metronidazole and sucralfate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Lidocaine and metronidazole and sucralfate only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Lidocaine- and metronidazole- and sucralfate-containing product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only lidocaine and metronidazole and sucralfate in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Lidocaine hydrochloride 40 mg/g and metronidazole 10 mg/g and sucralfate 70 mg/g cutaneous cream |
Has precise active ingredient |
True |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Lidocaine hydrochloride 40 mg/g and metronidazole 10 mg/g and sucralfate 70 mg/g cutaneous cream |
Has basis of strength substance (attribute) |
True |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Furazolidone 100 mg and metronidazole 300 mg oral tablet |
Has precise active ingredient |
True |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Furazolidone 100 mg and metronidazole 300 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely metronidazole 5 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug) |
Has precise active ingredient |
True |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely metronidazole 5 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug) |
Has basis of strength substance (attribute) |
True |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline hydrochloride 125 milligram/1 each conventional release oral capsule (clinical drug) |
Has precise active ingredient |
True |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline hydrochloride 125 milligram/1 each conventional release oral capsule (clinical drug) |
Has basis of strength substance (attribute) |
True |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely diloxanide furoate 250 milligram and metronidazole 200 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely diloxanide furoate 250 milligram and metronidazole 200 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Metronidazole 500 mg vaginal pessary |
Has precise active ingredient |
True |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Metronidazole 500 mg vaginal pessary |
Has basis of strength substance (attribute) |
True |
Metronidazole |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |